多中心非劣效随机对照试验研究方案:完全尺侧副韧带断裂(含Stener病变)患者主要非手术治疗(石膏固定)与立即手术加石膏固定后的功能结局与成本效果比较——MUSCAT研究
本研究为多中心随机对照非劣效试验,纳入18岁及以上急性完全尺侧副韧带断裂(含Stener病变)患者,随机分为石膏固定组与立即手术加石膏固定组,主要结局为6个月时密歇根手部结局问卷(MHQ)评分,并评估成本效果;作者假设石膏固定组功能结局非劣于手术组且成本更低。
要点
- 指南推荐对急性完全尺侧副韧带断裂(含Stener病变)行手术加石膏固定,但该推荐基于专家意见、解剖学理论及低质量观察性病例系列,缺乏高质量对比研究。
- 两组均采用4周不可拆卸石膏(拇指掌指关节及腕掌关节中立位)后4周可拆卸石膏固定。
- 石膏固定组在开始固定后2至3周复评拇指稳定性,若持续松弛则需二次手术;预计约十分之一的石膏固定组患者需二次手术。
核心结论
- 作者假设主要采用石膏固定的非手术治疗在功能结局方面非劣于立即手术加石膏固定,且成本更低。
- 若石膏固定非劣于手术治疗,该策略将通过避免手术减轻患者负担。
- 预计约十分之一的开始石膏固定的患者将在复评时需二次手术,导致这些患者完成治疗的时间长于立即手术的患者。
研究设计与样本
- 多中心随机对照非劣效试验(RCT)。
- 纳入18岁及以上、需治疗急性完全尺侧副韧带断裂(含Stener病变)的患者。
- 患者随机分配至石膏固定组或立即手术加石膏固定组。
主要发现
- 两组固定方案均为:拇指掌指关节(MCP)及腕掌关节(CMC)中立位不可拆卸石膏4周,随后可拆卸石膏4周。
- 石膏固定组在开始固定后2至3周复评拇指稳定性,以确定是否需要二次手术;若持续松弛则需二次手术。
- 主要结局为伤后6个月时密歇根手部结局问卷(MHQ)评估的手功能。
关键数值与推荐
- 主要结局指标为6个月时的MHQ评分。
- 非劣效界值原文未报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 指南推荐基于专家意见、解剖学理论及低质量观察性病例系列,缺乏高质量比较非手术与手术治疗的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines recommend operative treatment followed by cast immobilization for acute complete ulnar collateral ligament (UCL) ruptures, including Stener lesions. This recommendation is based on expert opinion, anatomic theories, and low-quality observational case series. High-quality studies comparing non-operative treatment to operative treatment are lacking. We hypothesize that primarily non-operative treatment with cast immobilization (cast immobilization) is non-inferior regarding functional outcome and carries concomitant lower costs compared with immediate operative treatment followed by cast immobilization (operative treatment) for complete UCL ruptures, including Stener lesions. METHODS: This is a multicenter randomized controlled non-inferiority trial (RCT) including patients of 18 years and above, requiring treatment for an acute complete UCL rupture, including Stener lesions. Patients are randomized to cast immobilization or operative treatment followed by cast immobilization. Immobilization consists of 4 weeks of a non-removable cast around the metacarpophalangeal (MCP) and carpometacarpal (CMC) joint of the thumb in a neutral position, followed by a removable cast for 4 weeks for both groups. Patients in the cast immobilization group are re-evaluated 2 to 3 weeks after the start of cast immobilization to examine thumb stability and determine if secondary surgery is required. In case of persistent laxity, secondary surgery is required. The primary outcome is hand function expressed as the Michigan Hand outcome Questionnaire (MHQ) at 6 months (from injury to 6 months after). DISCUSSION: If cast immobilization is non-inferior to operative treatment, the proposed treatment strategy will reduce patient burden by preventing surgery. It is expected that about one in ten patients who started with cast immobilization will need secondary surgery during re-evaluation. As a result, completion of the treatment will take longer for these patients compared to patients who received immediate operative treatment. TRIAL REGISTRATION: Central Committee on Research Involving Human Subjects (CCMO), NL78886.100.21; registered on 4 October 2021. Medical Research Ethics Committees United (MEC-U), R21.006; registered on 09 December 2021. Clinical Trial register, identifier: NCT05291260; retrospectively registered on 22 March 2022.
引用
- de Haas L, van Hoorn B, van de Lücht V, et al. Study protocol for a multicenter non-inferiority randomized controlled trial to assess functional outcomes and cost-effectiveness of a primarily non-operative treatment strategy with cast immobilization versus immediate operative treatment followed by cast immobilization for patients with complete ulnar collateral ligament ruptures, including Stener lesions: MUSCAT study. Trials. 2024. PMID: 39468632. doi:10.1186/s13063-024-08576-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。